phase readout
saveNCT05600920: A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE1. Conditions: Idiopathic CD4 Lymphopenia
view source ↗
comments(0)
5-min edit window · permanent after that